Jitteriness, irritability, and lethargy are all signs of in a newborn.

Asymptomatic hypoglycemia is common among infants with risk factors and has historically been treated by ensuring the infant is getting adequate nutrition, which typically involves supplementation (banked breast milk or formula) as well as assisting mother to maximize colostrum expression in the hours after birth.  In recent years many hospitals have started using oral dextrose gel to treat asymptomatic hypoglycemia as well.

Symptomatic hypoglycemia is less common.  Prompt intervention is necessary in these cases, with consideration of immediate IV dextrose in the infant who is not well appearing.  Symptoms such as suppressible tremors (jitteriness) and sleepiness occur in many infants who do not have hypoglycemia as part of normal newborn transition, so often these are “mild symptoms” of hypoglycemia and less invasive treatment is typically tried prior to IV dextrose.  The method for correcting hypoglycemia should be determined by the clinical status of the infant and considerations for how soon the intervention will normalize the glucose level.  If an infant overall appears well, attempts can be made to correct hypoglycemia by feeding the infant and/or giving dextrose gel.  Glucose absorption from rubbing dextrose gel on a baby’s buccal mucosa has similar response time to administering IV dextrose.  Additional evaluation for other underlying disorders should also be considered for the symptomatic infant with hypoglycemia, unless symptoms resolve promptly with glucose correction.

Within the first 4 hours of life:

Any glucose level less than 25 mg/dL in a baby with severe symptoms requires immediate IV fluid therapy.  In an asymptomatic baby, an initial glucose level (within the first 4 hours of life) of less than 25 mg/dL should prompt treatment with dextrose gel and an immediate feeding, with another glucose check in an hour. If the subsequent test is still <25 mg/dL, IV dextrose or repeating a dose of gel should be considered, depending on the clinical status of the infant. If the subsequent test is >25 but <35 mg/dL, the infant should again be given dextrose gel, fed and retested, although IV fluid therapy may be indicated for some patients in this group.

Between 4 - 24 hours of life:

Any glucose level less than 45 mg/dL in a baby with severe symptoms requires immediate IV fluid therapy.  In an asymptomatic baby, a glucose level of less than 45 mg/dL should prompt dextrose gel with immediate feeding, and another glucose check in an hour.  If the subsequent test is still <45 mg/dL, further attempts to correct the glucose with up to 3 total doses of categorized as dextrose gel and continued supplemental feeding should be attempted.  Infants who have persistently low glucoses (<45 mg/dL) should be considered for IV dextrose treatment.

Hypoglycemia can be associated with adverse neurologic outcomes, but in many cases these infants also have other risk factors or pathology.  Scientific evidence has not established a connection between isolated low glucose levels in asymptomatic infants and neurologic injury.

A change in behavior may be one of the first signs of illness in a newborn. Although a baby's activity level, appetite, and cries normally vary from day to day, even hour to hour, a distinct change in any of these areas may signal illness.

Generally, if your baby is alert and active when awake, is feeding well, and can be comforted when crying, occasional differences in these areas are normal. Consult your baby's doctor if you have concerns about your baby's behavior. Some behavior changes may indicate an illness is present, including the following:

  • Listlessness or lethargy. Lethargic or listless babies appear to have little or no energy, are drowsy or sluggish, and may sleep longer than usual. They may be hard to wake for feedings and even when awake, are not alert or attentive to sounds and visual stimulation. Sometimes, this can develop slowly and a parent may not notice the gradual change. Lethargy may be a sign of infection or other condition, such as low blood glucose (sugar). Consult your baby's doctor if your he or she becomes lethargic or has a change in activity level.

  • Poor feeding. Feeding problems may include difficulty with a baby's suck at the breast or bottle, lack of hunger, problems with spitting up, and weight loss.

    • Feeding difficulties due to a sucking problem may show up when a baby starts out at birth with a strong, vigorous suck and gradually become less effective at feedings over time, or when a baby starts out with a weak suck and does not eat effectively. This is especially common if he or she was born prematurely. Babies with a weak suck may not pull strongly or have a good latch while breastfeeding. The mother may not hear the baby swallowing or gulping during feedings. A mother's breasts may not feel full right before a feeding or she may not notice her breasts getting softer (emptying) after a feeding. Bottle-fed babies with a weak suck may need the bottle nipple "worked" or pumped to stimulate a suck. Feedings with either breastfed or bottle-fed babies with a weak suck may take a very long time, often more than 45 minutes.

    • After the first day or so, most newborns are ready to eat every 3 to 4 hours and show signs of hunger by sucking on fingers or a hand, crying, and making rooting motions. A sick baby may refuse feedings. A baby who sleeps continuously and shows little interest in feeding may be ill.

    • Spitting up and dribbling milk with burps or after feedings is fairly common in newborns. This is because the sphincter muscle between the stomach and the esophagus (the tube from the mouth to stomach) is weak and immature. However, forceful or projectile vomiting, or spitting up large amounts of milk after most feedings, can indicate a problem. In formula-fed babies, vomiting may occur after overfeeding, or because of an intolerance to formula. In breastfed or formula-fed babies, a physical condition that prevents normal digestion may cause vomiting. Discolored or green-tinged vomit may mean the baby has an intestinal obstruction.

    • Weight loss up to about 10% of birthweight is normal in the first 2 to 3 days after birth. However, the baby should reach his or her birthweight by 10 or 11 days old. Signs a baby is not gaining weight may include a thin, drawn face, loose skin, and a decreased number of wet or soiled diapers. Most doctors want to see a newborn in the office at the end of the first week to check his or her weight. Lack of weight gain or continued weight loss in a young baby may be a sign of illness or other conditions that need to be treated.

      Feeding problems can be a sign of other conditions and may lead to serious illness if untreated. Consult your baby's doctor if your baby has any difficulties taking or digesting feedings.

  • Persistent crying or irritability. All babies cry?this is their only way of communicating their needs to you. Babies also develop different types of cries for different needs, including hunger, sleepiness, loneliness, in need of a diaper change, and pain. At first, parents may not know how to interpret cries, but they usually can console a baby by meeting those needs. However, a baby who is continuously fretful and fussy, or cries for long periods, may be ill. Also, a baby may be very irritable if he or she is hurting. Colic, a common intestinal problem, can cause babies to cry inconsolably. Jitteriness or trembling may also be signs of illness.

    Examine your baby carefully to make sure there is not a physical problem, such as clothing pinching the baby, or a diaper pin sticking the baby. There may be a thread or even a hair tightly wound on a finger or toe. Look at the baby's abdomen for signs of swelling. Consult your baby's doctor promptly if your baby is crying for longer than usual or has other signs of illness.

  • 1. Roglic G. Diabetes in women: the global perspective. Int J Gynaecol Obstet. 2009;104 Suppl 1:S11–S13. [PubMed] [Google Scholar]

    2. Wang Z, Kanguru L, Hussein J, Fitzmaurice A, Ritchie K. Incidence of adverse outcomes associated with gestational diabetes mellitus in low- and middle-income countries. Int J Gynaecol Obstet. 2013;121:14–19. [PubMed] [Google Scholar]

    3. Mitanchez D, Burguet A, Simeoni U. Infants born to mothers with gestational diabetes mellitus: mild neonatal effects, a long-term threat to global health. J Pediatr. 2014;164:445–450. [PubMed] [Google Scholar]

    4. Simeoni U, Barker DJ. Offspring of diabetic pregnancy: long-term outcomes. Semin Fetal Neonatal Med. 2009;14:119–124. [PubMed] [Google Scholar]

    5. Pedersen J. Weight and length at birth of infants of diabetic mothers. Acta Endocrinol (Copenh) 1954;16:330–342. [PubMed] [Google Scholar]

    6. Ostlund I, Hanson U, Björklund A, Hjertberg R, Eva N, Nordlander E, Swahn ML, Wager J. Maternal and fetal outcomes if gestational impaired glucose tolerance is not treated. Diabetes Care. 2003;26:2107–2111. [PubMed] [Google Scholar]

    7. Ong KK, Diderholm B, Salzano G, Wingate D, Hughes IA, MacDougall J, Acerini CL, Dunger DB. Pregnancy insulin, glucose, and BMI contribute to birth outcomes in nondiabetic mothers. Diabetes Care. 2008;31:2193–2197. [PMC free article] [PubMed] [Google Scholar]

    8. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991–2002. [PubMed] [Google Scholar]

    9. HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes. 2009;58:453–459. [PMC free article] [PubMed] [Google Scholar]

    10. Vambergue A, Fajardy I. Consequences of gestational and pregestational diabetes on placental function and birth weight. World J Diabetes. 2011;2:196–203. [PMC free article] [PubMed] [Google Scholar]

    11. Catalano PM, Hauguel-De Mouzon S. Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? Am J Obstet Gynecol. 2011;204:479–487. [PMC free article] [PubMed] [Google Scholar]

    12. Falavigna M, Schmidt MI, Trujillo J, Alves LF, Wendland ER, Torloni MR, Colagiuri S, Duncan BB. Effectiveness of gestational diabetes treatment: a systematic review with quality of evidence assessment. Diabetes Res Clin Pract. 2012;98:396–405. [PubMed] [Google Scholar]

    13. Horvath K, Koch K, Jeitler K, Matyas E, Bender R, Bastian H, Lange S, Siebenhofer A. Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis. BMJ. 2010;340:c1395. [PMC free article] [PubMed] [Google Scholar]

    14. Hedderson MM, Ferrara A, Sacks DA. Gestational diabetes mellitus and lesser degrees of pregnancy hyperglycemia: association with increased risk of spontaneous preterm birth. Obstet Gynecol. 2003;102:850–856. [PubMed] [Google Scholar]

    15. Yogev Y, Langer O. Spontaneous preterm delivery and gestational diabetes: the impact of glycemic control. Arch Gynecol Obstet. 2007;276:361–365. [PubMed] [Google Scholar]

    16. Metzger BE, Persson B, Lowe LP, Dyer AR, Cruickshank JK, Deerochanawong C, Halliday HL, Hennis AJ, Liley H, Ng PC, et al. Hyperglycemia and adverse pregnancy outcome study: neonatal glycemia. Pediatrics. 2010;126:e1545–e1552. [PubMed] [Google Scholar]

    17. Hawdon JM. Babies born after diabetes in pregnancy: what are the short- and long-term risks and how can we minimise them? Best Pract Res Clin Obstet Gynaecol. 2011;25:91–104. [PubMed] [Google Scholar]

    18. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352:2477–2486. [PubMed] [Google Scholar]

    19. Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, Wapner RJ, Varner MW, Rouse DJ, Thorp JM, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361:1339–1348. [PMC free article] [PubMed] [Google Scholar]

    20. Hay WW, Rozance PJ. Continuous glucose monitoring for diagnosis and treatment of neonatal hypoglycemia. J Pediatr. 2010;157:180–182. [PMC free article] [PubMed] [Google Scholar]

    21. Deshpande S, Ward Platt M. The investigation and management of neonatal hypoglycaemia. Semin Fetal Neonatal Med. 2005;10:351–361. [PubMed] [Google Scholar]

    22. Mitanchez D. Management of infants born to mothers with gestational diabetes. Paediatric environment. Diabetes Metab. 2010;36:587–594. [PubMed] [Google Scholar]

    23. Demarini S, Mimouni F, Tsang RC, Khoury J, Hertzberg V. Impact of metabolic control of diabetes during pregnancy on neonatal hypocalcemia: a randomized study. Obstet Gynecol. 1994;83:918–922. [PubMed] [Google Scholar]

    24. Cordero L, Treuer SH, Landon MB, Gabbe SG. Management of infants of diabetic mothers. Arch Pediatr Adolesc Med. 1998;152:249–254. [PubMed] [Google Scholar]

    25. Alzaim M, Wood RJ. Vitamin D and gestational diabetes mellitus. Nutr Rev. 2013;71:158–167. [PubMed] [Google Scholar]

    26. Mimouni F, Loughead J, Miodovnik M, Khoury J, Tsang RC. Early neonatal predictors of neonatal hypocalcemia in infants of diabetic mothers: an epidemiologic study. Am J Perinatol. 1990;7:203–206. [PubMed] [Google Scholar]

    27. Cetin H, Yalaz M, Akisu M, Kultursay N. Polycythaemia in infants of diabetic mothers: β-hydroxybutyrate stimulates erythropoietic activity. J Int Med Res. 2011;39:815–821. [PubMed] [Google Scholar]

    28. Mitanchez D. Foetal and neonatal complications in gestational diabetes: perinatal mortality, congenital malformations, macrosomia, shoulder dystocia, birth injuries, neonatal complications. Diabetes Metab. 2010;36:617–627. [PubMed] [Google Scholar]

    29. Al-Agha R, Kinsley BT, Finucane FM, Murray S, Daly S, Foley M, Smith SC, Firth RG. Caesarean section and macrosomia increase transient tachypnoea of the newborn in type 1 diabetes pregnancies. Diabetes Res Clin Pract. 2010;89:e46–e48. [PubMed] [Google Scholar]

    30. Hernández-Díaz S, Van Marter LJ, Werler MM, Louik C, Mitchell AA. Risk factors for persistent pulmonary hypertension of the newborn. Pediatrics. 2007;120:e272–e282. [PubMed] [Google Scholar]

    31. Hay WW. Care of the infant of the diabetic mother. Curr Diab Rep. 2012;12:4–15. [PubMed] [Google Scholar]

    32. Veille JC, Sivakoff M, Hanson R, Fanaroff AA. Interventricular septal thickness in fetuses of diabetic mothers. Obstet Gynecol. 1992;79:51–54. [PubMed] [Google Scholar]

    33. Oberhoffer R, Högel J, Stoz F, Kohne E, Lang D. Cardiac and extracardiac complications in infants of diabetic mothers and their relation to parameters of carbohydrate metabolism. Eur J Pediatr. 1997;156:262–265. [PubMed] [Google Scholar]

    34. Ullmo S, Vial Y, Di Bernardo S, Roth-Kleiner M, Mivelaz Y, Sekarski N, Ruiz J, Meijboom EJ. Pathologic ventricular hypertrophy in the offspring of diabetic mothers: a retrospective study. Eur Heart J. 2007;28:1319–1325. [PubMed] [Google Scholar]

    35. Garcia-Flores J, Jañez M, Gonzalez MC, Martinez N, Espada M, Gonzalez A. Fetal myocardial morphological and functional changes associated with well-controlled gestational diabetes. Eur J Obstet Gynecol Reprod Biol. 2011;154:24–26. [PubMed] [Google Scholar]

    36. Chu C, Gui YH, Ren YY, Shi LY. The impacts of maternal gestational diabetes mellitus (GDM) on fetal hearts. Biomed Environ Sci. 2012;25:15–22. [PubMed] [Google Scholar]

    37. Balsells M, García-Patterson A, Gich I, Corcoy R. Major congenital malformations in women with gestational diabetes mellitus: a systematic review and meta-analysis. Diabetes Metab Res Rev. 2012;28:252–257. [PubMed] [Google Scholar]

    38. Aberg A, Westbom L, Källén B. Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum Dev. 2001;61:85–95. [PubMed] [Google Scholar]

    39. Schaefer-Graf UM, Buchanan TA, Xiang A, Songster G, Montoro M, Kjos SL. Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes. Am J Obstet Gynecol. 2000;182:313–320. [PubMed] [Google Scholar]

    40. Corrigan N, Brazil DP, McAuliffe F. Fetal cardiac effects of maternal hyperglycemia during pregnancy. Birth Defects Res A Clin Mol Teratol. 2009;85:523–530. [PubMed] [Google Scholar]

    41. Anoon SS, Rizk DE, Ezimokhai M. Obstetric outcome of excessively overgrown fetuses (& gt; or = 5000 g): a case-control study. J Perinat Med. 2003;31:295–301. [PubMed] [Google Scholar]

    42. Langer O, Yogev Y, Most O, Xenakis EM. Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol. 2005;192:989–997. [PubMed] [Google Scholar]

    43. Cornblath M, Hawdon JM, Williams AF, Aynsley-Green A, Ward-Platt MP, Schwartz R, Kalhan SC. Controversies regarding definition of neonatal hypoglycemia: suggested operational thresholds. Pediatrics. 2000;105:1141–1145. [PubMed] [Google Scholar]

    44. Zafeiriou DI, Psychogiou K. Obstetrical brachial plexus palsy. Pediatr Neurol. 2008;38:235–242. [PubMed] [Google Scholar]

    45. Bromiker R, Rachamim A, Hammerman C, Schimmel M, Kaplan M, Medoff-Cooper B. Immature sucking patterns in infants of mothers with diabetes. J Pediatr. 2006;149:640–643. [PubMed] [Google Scholar]

    46. Ellis H, Kumar R, Kostyrka B. Neonatal small left colon syndrome in the offspring of diabetic mothers-an analysis of 105 children. J Pediatr Surg. 2009;44:2343–2346. [PubMed] [Google Scholar]

    47. Sheffield JS, Butler-Koster EL, Casey BM, McIntire DD, Leveno KJ. Maternal diabetes mellitus and infant malformations. Obstet Gynecol. 2002;100:925–930. [PubMed] [Google Scholar]

    48. Correa A, Gilboa SM, Besser LM, Botto LD, Moore CA, Hobbs CA, Cleves MA, Riehle-Colarusso TJ, Waller DK, Reece EA. Diabetes mellitus and birth defects. Am J Obstet Gynecol. 2008;199:237.e1–237.e9. [PMC free article] [PubMed] [Google Scholar]

    49. García-Patterson A, Erdozain L, Ginovart G, Adelantado JM, Cubero JM, Gallo G, de Leiva A, Corcoy R. In human gestational diabetes mellitus congenital malformations are related to pre-pregnancy body mass index and to severity of diabetes. Diabetologia. 2004;47:509–514. [PubMed] [Google Scholar]

    50. Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation. 2006;114:1873–1882. [PubMed] [Google Scholar]

    51. Chang TI, Horal M, Jain SK, Wang F, Patel R, Loeken MR. Oxidant regulation of gene expression and neural tube development: Insights gained from diabetic pregnancy on molecular causes of neural tube defects. Diabetologia. 2003;46:538–545. [PubMed] [Google Scholar]

    52. Zhao Z, Yang P, Eckert RL, Reece EA. Caspase-8: a key role in the pathogenesis of diabetic embryopathy. Birth Defects Res B Dev Reprod Toxicol. 2009;86:72–77. [PMC free article] [PubMed] [Google Scholar]

    53. Reece EA. Diabetes-induced birth defects: what do we know? What can we do? Curr Diab Rep. 2012;12:24–32. [PubMed] [Google Scholar]

    54. Allen VM, Armson BA, Wilson RD, Allen VM, Blight C, Gagnon A, Johnson JA, Langlois S, Summers A, Wyatt P, et al. Teratogenicity associated with pre-existing and gestational diabetes. J Obstet Gynaecol Can. 2007;29:927–944. [Google Scholar]

    55. Dudley DJ. Diabetic-associated stillbirth: incidence, pathophysiology, and prevention. Obstet Gynecol Clin North Am. 2007;34:293–307, ix. [PubMed] [Google Scholar]

    56. Silver RM, Varner MW, Reddy U, Goldenberg R, Pinar H, Conway D, Bukowski R, Carpenter M, Hogue C, Willinger M, et al. Work-up of stillbirth: a review of the evidence. Am J Obstet Gynecol. 2007;196:433–444. [PMC free article] [PubMed] [Google Scholar]

    57. Cundy T, Gamble G, Townend K, Henley PG, MacPherson P, Roberts AB. Perinatal mortality in Type 2 diabetes mellitus. Diabet Med. 2000;17:33–39. [PubMed] [Google Scholar]

    58. Melamed N, Chen R, Soiberman U, Ben-Haroush A, Hod M, Yogev Y. Spontaneous and indicated preterm delivery in pregestational diabetes mellitus: etiology and risk factors. Arch Gynecol Obstet. 2008;278:129–134. [PubMed] [Google Scholar]

    59. Ehrenberg HM, Mercer BM, Catalano PM. The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol. 2004;191:964–968. [PubMed] [Google Scholar]

    60. Jolly MC, Sebire NJ, Harris JP, Regan L, Robinson S. Risk factors for macrosomia and its clinical consequences: a study of 350,311 pregnancies. Eur J Obstet Gynecol Reprod Biol. 2003;111:9–14. [PubMed] [Google Scholar]

    61. HAPO Study Cooperative Research Group. Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study: associations with maternal body mass index. BJOG. 2010;117:575–584. [PubMed] [Google Scholar]

    62. Owens LA, O’Sullivan EP, Kirwan B, Avalos G, Gaffney G, Dunne F. ATLANTIC DIP: the impact of obesity on pregnancy outcome in glucose-tolerant women. Diabetes Care. 2010;33:577–579. [PMC free article] [PubMed] [Google Scholar]

    63. Sewell MF, Huston-Presley L, Super DM, Catalano P. Increased neonatal fat mass, not lean body mass, is associated with maternal obesity. Am J Obstet Gynecol. 2006;195:1100–1103. [PubMed] [Google Scholar]

    64. Tennant PW, Rankin J, Bell R. Maternal body mass index and the risk of fetal and infant death: a cohort study from the North of England. Hum Reprod. 2011;26:1501–1511. [PMC free article] [PubMed] [Google Scholar]

    65. Aune D, Saugstad OD, Henriksen T, Tonstad S. Maternal body mass index and the risk of fetal death, stillbirth, and infant death: a systematic review and meta-analysis. JAMA. 2014;311:1536–1546. [PubMed] [Google Scholar]

    66. Stothard KJ, Tennant PW, Bell R, Rankin J. Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis. JAMA. 2009;301:636–650. [PubMed] [Google Scholar]

    67. Rasmussen SA, Chu SY, Kim SY, Schmid CH, Lau J. Maternal obesity and risk of neural tube defects: a metaanalysis. Am J Obstet Gynecol. 2008;198:611–619. [PubMed] [Google Scholar]

    68. Watkins ML, Rasmussen SA, Honein MA, Botto LD, Moore CA. Maternal obesity and risk for birth defects. Pediatrics. 2003;111:1152–1158. [PubMed] [Google Scholar]

    69. Waller DK, Shaw GM, Rasmussen SA, Hobbs CA, Canfield MA, Siega-Riz AM, Gallaway MS, Correa A. Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med. 2007;161:745–750. [PubMed] [Google Scholar]

    70. Torloni MR, Betrán AP, Horta BL, Nakamura MU, Atallah AN, Moron AF, Valente O. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev. 2009;10:194–203. [PubMed] [Google Scholar]

    71. Kim SY, England L, Wilson HG, Bish C, Satten GA, Dietz P. Percentage of gestational diabetes mellitus attributable to overweight and obesity. Am J Public Health. 2010;100:1047–1052. [PMC free article] [PubMed] [Google Scholar]

    72. Langer O, Yogev Y, Xenakis EM, Brustman L. Overweight and obese in gestational diabetes: the impact on pregnancy outcome. Am J Obstet Gynecol. 2005;192:1768–1776. [PubMed] [Google Scholar]

    73. Catalano PM, McIntyre HD, Cruickshank JK, McCance DR, Dyer AR, Metzger BE, Lowe LP, Trimble ER, Coustan DR, Hadden DR, et al. The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care. 2012;35:780–786. [PMC free article] [PubMed] [Google Scholar]

    74. Roman AS, Rebarber A, Fox NS, Klauser CK, Istwan N, Rhea D, Saltzman D. The effect of maternal obesity on pregnancy outcomes in women with gestational diabetes. J Matern Fetal Neonatal Med. 2011;24:723–727. [PubMed] [Google Scholar]

    75. Zhang X, Decker A, Platt RW, Kramer MS. How big is too big? The perinatal consequences of fetal macrosomia. Am J Obstet Gynecol. 2008;198:517.e1–517.e6. [PubMed] [Google Scholar]

    76. Esakoff TF, Cheng YW, Sparks TN, Caughey AB. The association between birthweight 4000 g or greater and perinatal outcomes in patients with and without gestational diabetes mellitus. Am J Obstet Gynecol. 2009;200:672.e1–672.e4. [PubMed] [Google Scholar]

    77. Das S, Irigoyen M, Patterson MB, Salvador A, Schutzman DL. Neonatal outcomes of macrosomic births in diabetic and non-diabetic women. Arch Dis Child Fetal Neonatal Ed. 2009;94:F419–F422. [PubMed] [Google Scholar]

    78. Guariguata L, Linnenkamp U, Beagley J, Whiting DR, Cho NH. Global estimates of the prevalence of hyperglycaemia in pregnancy. Diabetes Res Clin Pract. 2014;103:176–185. [PubMed] [Google Scholar]

    79. Seshiah V, Balaji V, Balaji MS, Paneerselvam A, Kapur A. Pregnancy and diabetes scenario around the world: India. Int J Gynaecol Obstet. 2009;104 Suppl 1:S35–S38. [PubMed] [Google Scholar]

    80. Koyanagi A, Zhang J, Dagvadorj A, Hirayama F, Shibuya K, Souza JP, Gülmezoglu AM. Macrosomia in 23 developing countries: an analysis of a multicountry, facility-based, cross-sectional survey. Lancet. 2013;381:476–483. [PubMed] [Google Scholar]

    81. Diagnostic criteria and classification of hyperglycemia first detected in pregnancy. Geneva, Switzerland: World Health Organisation; 2013. Available from: http://www.who.int/diabetes/publications/Hyperglycaemia_In_Pregnancy/en/